Ewa Paszkiewicz-Kozik

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Patient Reported

Lipopolysaccharide Induced

Top Venues

BioMed research international

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Ewa Paszkiewicz-Kozik, Wojciech Michalski, Michał Taszner, Monika Mordak-Domagała, Joanna Romejko-Jarosinska, Wanda Knopińska-Posłuszny, Jacek Najda, Anna Borawska, Monika Chełstowska, Monika Świerkowska, Anna Dąbrowska-Iwanicka, Agata Malenda, Agnieszka Druzd-Sitek, Robert Konecki, Beata Kumiega, Michał Osowiecki, Beata Ostrowska, Tomasz Szpila, Marcin Szymański, Łukasz Targoński, Katarzyna Domańska-Czyż, Lidia Popławska, Sebastian Giebel, Andrzej Lange, Andrzej Pluta, Jan Maciej Zaucha, Grzegorz Rymkiewicz, Jan Walewski
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma. British journal of haematology 198 (1) (2022)
Pier Luigi Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro, Ewa Paszkiewicz-Kozik, Robin Gasiorowski, Nathalie A Johnson, José S R Oliveira, Valeria Buccheri, Guilherme Fleury Perini, Michael J Dickinson, Andrew Bruce McDonald, Muhit Özcan, Naohiro Sekiguchi, Ying Zhu, Monika Raut, Todd L Saretsky, Akash Nahar, John George Kuruvilla
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma. Blood advances (2021)
Ewa Paszkiewicz-Kozik, Agnieszka Paziewska, Maria Kulecka, Michalina Dabrowska, Anna Kluska, Aneta Bałabas, Magdalena Piątkowska, Filip Ambrozkiewicz, Joanna Tajer, Włodzimierz Osiadacz, Joanna Romejko-Jarosinska, Martyna Kotarska, Natalia Zeber-Lubecka, Jakub Karczmarski, Lidia Popławska, Michal Mikula, Piotr Lukasz Rutkowski, Jan Walewski, Jerzy Ostrowski
Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs. BioMed research international 2021 (2021)